Terminology Service < Semantic Lookup Platform

All terms in HP

Label	Id	Description
Hypoplastic nasal septum	HP_0005104	[Underdevelopment of the nasal septum.]
Deep anterior chamber	HP_0007765	[Increased depth of the anterior chamber, i.e., the anteroposterior distance between the cornea and the iris is increased.]
High-frequency hearing impairment	HP_0005101	[A type of hearing impairment affecting primarily the higher frequencies of sound (3,000 to 6,000 Hz).]
Cochlear degeneration	HP_0005102	[Deterioration or loss of the tissues of the cochlea.]
Retinal telangiectasia	HP_0007763	[Dilatation of small blood vessels of the retina.]
Premature birth following premature rupture of fetal membranes	HP_0005100
Premature rupture of membranes	HP_0001788	[Premature rupture of membranes (PROM) is a condition which occurs in pregnancy when the amniotic sac ruptures more than an hour before the onset of labor.]
Pericentral scotoma	HP_0007761	[A scotoma (area of diminished vision within the visual field) that surrounds the central fixation point.]
Crystalline corneal dystrophy	HP_0007760
Increased CSF homocarnosine concentration	HP_0500242	[Abnormally increased levels of homocarnosine in cerebrospinal fluid.]
Abnormal CSF homocarnosine concentration	HP_0500241	[Any deviation from the normal concentration of homocarnosine in the cerebrospinal fluid.]
Abnormal CSF ornithine concentration	HP_0500243	[Any deviation from the normal concentration of ornithine in the cerebrospinal fluid.]
Increased CSF ornithine concentration	HP_0500244	[Abnormally increased levels of ornithine in cerebrospinal fluid.]
Abnormal CSF citrulline concentration	HP_0500245	[Any deviation from the normal concentration of citrulline in the cerebrospinal fluid.]
myeloid dendritic cell activation	GO_0001773	[The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.]
myeloid cell activation involved in immune response	GO_0002275	[A change in the morphology or behavior of a myeloid cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.]
Abnormal CSF carnosine concentration	HP_0500240	[Any deviation from the normal concentration of carnosine in the cerebrospinal fluid.]
myeloid leukocyte activation	GO_0002274	[A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.]
Increased CSF citrulline concentration	HP_0500246	[Abnormally increased levels of citrulline in cerebrospinal fluid.]
Abnormal CSF alpha-aminobutyrate concentration	HP_0500247	[Any deviation from the normal concentration of alpha-aminobutyrate in the cerebrospinal fluid.]